1. JNK signaling as a target for anticancer therapy
   Kamal S. Abdelrahman et al, 2021, Pharmacological Reports CrossRef
2. Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs
   Ewelina Węglarz-Tomczak et al, 2018, Oncotarget CrossRef
3. Chrysophanol induces cell death and inhibits invasiveness via mitochondrial calcium overload in ovarian cancer cells
   Whasun Lim et al, 2018, Journal of Cellular Biochemistry CrossRef
4. Neuroprotective Effect of Luteolin-7-O-Glucoside against 6-OHDA-Induced Damage in Undifferentiated and RA-Differentiated SH-SY5Y Cells
   Stephanie Cristine Hepp Rehfeldt et al, 2022, International Journal of Molecular Sciences CrossRef
5. Pharmacological Activities of Aminophenoxazinones
   Jesús G. Zorrilla et al, 2021, Molecules CrossRef
6. Targeting Lysosomes in Colorectal Cancer: Exploring the Anticancer Activity of a New Benzo[a]phenoxazine Derivative
   João C. C. Ferreira et al, 2022, International Journal of Molecular Sciences CrossRef
7. The synthesis and applications of bioactive phenoxazinones
   Savvas N. Georgiades, 2024, CrossRef
8. A Highly Selective In Vitro JNK3 Inhibitor, FMU200, Restores Mitochondrial Membrane Potential and Reduces Oxidative Stress and Apoptosis in SH-SY5Y Cells
   Stephanie Cristine Hepp Rehfeldt et al, 2021, International Journal of Molecular Sciences CrossRef